{"id":"https://openalex.org/W2170088090","doi":"https://doi.org/10.1345/aph.1l066","title":"Association Between Selective Serotonin-Reuptake Inhibitors, Second-Generation Antipsychotics, and Neuroleptic Malignant Syndrome","display_name":"Association Between Selective Serotonin-Reuptake Inhibitors, Second-Generation Antipsychotics, and Neuroleptic Malignant Syndrome","alternate_titles":[],"publication_year":2008,"publication_date":"2008-07-29","ids":{"openalex":"https://openalex.org/W2170088090","doi":"https://doi.org/10.1345/aph.1l066","mag":"2170088090","pmid":"https://pubmed.ncbi.nlm.nih.gov/18628446"},"language":"en","primary_location":{"id":"doi:10.1345/aph.1l066","doi":"https://doi.org/10.1345/aph.1l066","is_oa":false,"landing_page_url":"https://doi.org/10.1345/aph.1l066","pdf_url":null,"source":{"id":"https://openalex.org/S113426163","display_name":"Annals of Pharmacotherapy","issn_l":"0012-6578","issn":["0012-6578","1060-0280","1542-6270"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Pharmacotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2170088090"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005232308","display_name":"Debra L. Stevens","orcid":"https://orcid.org/0000-0002-1655-5049","observed_orcids":["https://orcid.org/0000-0002-1655-5049"]},"institutions":[{"id":"https://openalex.org/I4210120222","display_name":"Oklahoma Department of Human Services","ror":"https://ror.org/02pq27251","country_code":"US","type":"government","lineage":["https://openalex.org/I4210120222"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Debra L Stevens","raw_affiliation_strings":["Oklahoma DHS Developmental Disabilities Services Division, 2400 N. Lincoln Blvd., 2nd Floor, Oklahoma City, OK 73125, fax 405/522\u20133037,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oklahoma DHS Developmental Disabilities Services Division, 2400 N. Lincoln Blvd., 2nd Floor, Oklahoma City, OK 73125, fax 405/522\u20133037,","institution_ids":["https://openalex.org/I4210120222"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5005232308"],"corresponding_institution_ids":["https://openalex.org/I4210120222"],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":0.6391,"has_fulltext":false,"cited_by_count":59,"citation_normalized_percentile":{"value":0.50346192,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"42","issue":"9","first_page":"1290","last_page":"1297"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11921","display_name":"Electroconvulsive Therapy Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11921","display_name":"Electroconvulsive Therapy Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neuroleptic-malignant-syndrome","display_name":"neuroleptic malignant syndrome","score":0.9990000128746033},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.9649999737739563},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":1.0},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.5789999961853027},{"id":"https://openalex.org/keywords/serotonin","display_name":"serotonin","score":0.3700000047683716},{"id":"https://openalex.org/keywords/dopamine-release","display_name":"dopamine release","score":0.9620000123977661},{"id":"https://openalex.org/keywords/hypodopaminergic-state","display_name":"hypodopaminergic state","score":0.9290000200271606},{"id":"https://openalex.org/keywords/pharmacokinetic-interactions","display_name":"pharmacokinetic interactions","score":0.6830000281333923},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.7409999966621399},{"id":"https://openalex.org/keywords/antidepressant-treatment","display_name":"antidepressant treatment","score":0.4099999964237213}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.869181752204895},{"id":"https://openalex.org/C2780179036","wikidata":"https://www.wikidata.org/wiki/Q616181","display_name":"Serotonin syndrome","level":5,"score":0.6086267828941345},{"id":"https://openalex.org/C2910584757","wikidata":"https://www.wikidata.org/wiki/Q334477","display_name":"Serotonin Uptake Inhibitors","level":5,"score":0.5837113857269287},{"id":"https://openalex.org/C2777964233","wikidata":"https://www.wikidata.org/wiki/Q1424956","display_name":"Neuroleptic malignant syndrome","level":2,"score":0.5517284870147705},{"id":"https://openalex.org/C31487548","wikidata":"https://www.wikidata.org/wiki/Q4859664","display_name":"Reuptake inhibitor","level":4,"score":0.5095908641815186},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4607890546321869},{"id":"https://openalex.org/C2780092697","wikidata":"https://www.wikidata.org/wiki/Q7455053","display_name":"Serotonin reuptake inhibitor","level":4,"score":0.4475536644458771},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.43617239594459534},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.3737800717353821},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.37031102180480957},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3130238652229309},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.1608884632587433},{"id":"https://openalex.org/C37000724","wikidata":"https://www.wikidata.org/wiki/Q50430226","display_name":"Serotonergic","level":4,"score":0.09339892864227295},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0643889307975769}],"mesh":[{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009459","descriptor_name":"Neuroleptic Malignant Syndrome","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D009459","descriptor_name":"Neuroleptic Malignant Syndrome","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1345/aph.1l066","doi":"https://doi.org/10.1345/aph.1l066","is_oa":false,"landing_page_url":"https://doi.org/10.1345/aph.1l066","pdf_url":null,"source":{"id":"https://openalex.org/S113426163","display_name":"Annals of Pharmacotherapy","issn_l":"0012-6578","issn":["0012-6578","1060-0280","1542-6270"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Pharmacotherapy","raw_type":"journal-article"},{"id":"pmid:18628446","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18628446","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Annals of pharmacotherapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":62,"referenced_works":["https://openalex.org/W1499369734","https://openalex.org/W1528478735","https://openalex.org/W1532390389","https://openalex.org/W1557130291","https://openalex.org/W1943768918","https://openalex.org/W1970839880","https://openalex.org/W1973013710","https://openalex.org/W1977998259","https://openalex.org/W1980924127","https://openalex.org/W1981090707","https://openalex.org/W1981586495","https://openalex.org/W1985883403","https://openalex.org/W1987358106","https://openalex.org/W1988671272","https://openalex.org/W1994221473","https://openalex.org/W1995539988","https://openalex.org/W2003056444","https://openalex.org/W2003401874","https://openalex.org/W2003655003","https://openalex.org/W2009069233","https://openalex.org/W2017251333","https://openalex.org/W2022557539","https://openalex.org/W2023011547","https://openalex.org/W2030914194","https://openalex.org/W2031792451","https://openalex.org/W2032036821","https://openalex.org/W2033712352","https://openalex.org/W2045380437","https://openalex.org/W2048979653","https://openalex.org/W2049958630","https://openalex.org/W2064248719","https://openalex.org/W2066298737","https://openalex.org/W2070880575","https://openalex.org/W2097639454","https://openalex.org/W2098797772","https://openalex.org/W2099471595","https://openalex.org/W2100989500","https://openalex.org/W2103398163","https://openalex.org/W2103686898","https://openalex.org/W2104696127","https://openalex.org/W2105070570","https://openalex.org/W2120484567","https://openalex.org/W2135891971","https://openalex.org/W2136798331","https://openalex.org/W2143789551","https://openalex.org/W2148005654","https://openalex.org/W2149006846","https://openalex.org/W2158824493","https://openalex.org/W2167220145","https://openalex.org/W2168592903","https://openalex.org/W2170692335","https://openalex.org/W2172053951","https://openalex.org/W2321497117","https://openalex.org/W2339505404","https://openalex.org/W2399939094","https://openalex.org/W2409394445","https://openalex.org/W2412232114","https://openalex.org/W2419552051","https://openalex.org/W2539583278","https://openalex.org/W3145267238","https://openalex.org/W4231301269","https://openalex.org/W4297952970"],"related_works":["https://openalex.org/W2054702865","https://openalex.org/W2040484281","https://openalex.org/W2560673463","https://openalex.org/W1992284381","https://openalex.org/W7096717996","https://openalex.org/W1574332102","https://openalex.org/W2313026882","https://openalex.org/W4387996482","https://openalex.org/W2322732145"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"review":[2],"the":[3,13,102,126,153,212,247],"published":[4,41],"reports":[5,67,197],"of":[6,15,32,39,49,87,89,101,128,145,150,155,195,214,224,233,250],"neuroleptic":[7],"malignant":[8],"syndrome":[9],"(NMS)":[10],"associated":[11,51,228],"with":[12,52,71,110,121,147,211,229],"use":[14,149,223],"selective":[16],"serotonin-reuptake":[17],"inhibitors":[18],"(SSRIs)":[19],"and":[20,99,165],"second-generation":[21,53,78,112,239],"antipsychotics.":[22,174,240],"DATA":[23,61,104],"SOURCE:":[24],"Information":[25],"was":[26,55,69],"selected":[27],"from":[28,65],"a":[29,169,180,207],"MEDLINE":[30,45],"search":[31,38],"English-language":[33],"literature":[34],"(1950-May":[35],"2008).":[36],"Manual":[37],"all":[40,66],"cases":[42,185],"indexed":[43],"in":[44,92,182,204,236],"(English":[46],"language":[47],"only)":[48],"NMS":[50,90,106,129,146,184,234],"antipsychotics":[54],"also":[56,178],"performed.":[57],"STUDY":[58],"SELECTION":[59],"AND":[60],"EXTRACTION:":[62],"Pertinent":[63],"information":[64],"obtained":[68],"included,":[70],"specific":[72],"emphasis":[73],"on":[74,157],"patient":[75],"age,":[76],"sex,":[77],"antipsychotic":[79,113,191,219],"involved,":[80,85],"SSRI":[81,188,216],"or":[82,133,136],"other":[83,122],"antidepressant":[84],"time":[86],"onset":[88],"symptoms":[91],"relation":[93],"to":[94,199,217],"medication":[95],"changes,":[96],"treatment":[97],"administered,":[98],"outcome":[100],"reaction.":[103],"SYNTHESIS:":[105],"has":[107],"been":[108],"reported":[109],"every":[111],"agent.":[114],"It":[115],"is":[116,152],"unclear":[117],"whether":[118],"concomitant":[119,148],"therapy":[120],"agents":[123],"may":[124,167,177,226],"increase":[125],"risk":[127,144,232],"development":[130,235,249],"via":[131],"pharmacodynamic":[132,140],"pharmacokinetic":[134],"mechanisms":[135],"both.":[137],"The":[138,222],"suggested":[139],"mechanism":[141],"for":[142,246],"increased":[143,231],"SSRIs":[151,225],"effect":[154],"serotonin":[156],"dopamine":[158,163],"release.":[159],"Serotonin":[160],"further":[161],"inhibits":[162],"release":[164],"thereby":[166],"worsen":[168],"hypodopaminergic":[170],"state":[171],"induced":[172],"by":[173,189],"Pharmacokinetic":[175],"factors":[176],"play":[179],"role":[181],"some":[183,205],"involving":[186],"an":[187,215,230],"increasing":[190],"concentrations.":[192],"An":[193],"examination":[194],"case":[196],"seems":[198],"indicate":[200],"that":[201],"at":[202],"least":[203],"cases,":[206],"temporal":[208],"relationship":[209],"exists":[210],"addition":[213],"existing":[218],"therapy.":[220],"CONCLUSIONS:":[221],"be":[227],"those":[237],"receiving":[238],"Clinicians":[241],"should":[242],"closely":[243],"monitor":[244],"patients":[245],"potential":[248],"NMS.":[251]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2170088090","counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":3},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
